Benzphetamine tablets recalled due to label mix-up with Benzonatate
Calvin Scott & Company recalled Benzphetamine 50mg tablets due to a labeling error where bottles labeled as Benzonatate 100mg capsules contained Benzphetamine 50mg tablets and vice versa. One physician in Alpharetta, Georgia received 13 affected bottles.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The hazard is a labeling error resulting in wrong medications in mislabeled bottles; however, since the hazard is theoretical and no adverse effects have been documented, the severity is rated as moderate.
Plain-English summary
Calvin Scott & Company, Inc. is recalling Benzphetamine 50mg tablets due to a labeling error that resulted in incorrect product-to-label matching.
The company discovered that bottles labeled as Benzonatate 100mg capsules actually contained Benzphetamine 50mg tablets, while bottles labeled as Benzphetamine 50mg tablets contained Benzonatate 100mg capsules. This mix-up affects lot CS-20274-005 with an expiration date of May 2022.
The recall affects 13 bottles that were distributed to one physician in Alpharetta, Georgia.
If you have received these bottles, do not use them and contact your pharmacist or physician to verify the contents and receive the correct medication.
The recalled product
- Product
- Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 10702-0040-50
- Manufacturer
- Calvin Scott & Company, Inc.
- Category
- Drug
- Hazard
- mis-labeling
- label-mix-up
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- CSI Lot: CS-20274-005
- Exp 5/22
Distribution
Distributed in 1 state:
- GA
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27